Koppers swings to $147.5 million Q2 net loss on $215.8 million impairment charges
Koppers reported second quarter 2026 net sales of $520.1 million, up 3.0% from a year earlier, but a net loss of $147.5 million, driven by $215.8 million of impairment, restructuring and plant closure costs. Adjusted EPS fell to $1.37 from $1.48, and the company lowered the top end of its 2026 adjusted EPS guidance to $3.80 to $4.20 from $3.80 to $4.60, saying profitability will likely be toward the lower end of prior guidance.
Key points
- Net loss of $147.5 million, or $(7.71) diluted EPS, versus net income of $16.4 million, or $0.81 diluted EPS, in Q2 2025
- Adjusted EBITDA of $71.0 million versus $77.1 million; Performance Chemicals rose to $37.7 million from $28.7 million, while Carbon Materials and Chemicals fell to $7.6 million from $16.8 million
- 2026 adjusted EPS guidance of $3.80 to $4.20 versus prior $3.80 to $4.60; adjusted EBITDA guidance of $240 million to $250 million versus prior $240 million to $260 million
- Record year-to-date operating cash flow of $96.3 million and free cash flow of $72.6 million; $47.4 million returned to shareholders
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 2:07 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.